Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
3.745
+0.025 (0.67%)
At close: Sep 15, 2025, 4:00 PM EDT
3.720
-0.025 (-0.67%)
After-hours: Sep 15, 2025, 4:10 PM EDT
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of $135.57 million as of September 15, 2025. Its market cap has decreased by -35.14% in one year.
Market Cap
135.57M
Enterprise Value
-6.24M
1-Year Change
-35.14%
Ranking
Category
Stock Price
$3.75
Market Cap Chart
Since the IPO on February 21, 2018, Molecular Partners AG's market cap has decreased from $595.47M to $135.57M, a decrease of -77.23%. That is a compound annual growth rate of -17.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 135.57M | -17.84% |
| Dec 30, 2024 | 165.01M | 22.94% |
| Dec 29, 2023 | 134.22M | -38.09% |
| Dec 30, 2022 | 216.81M | -65.56% |
| Dec 30, 2021 | 629.47M | -8.03% |
| Dec 30, 2020 | 684.44M | 75.63% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |